Stock Groups

Roche shareholders approve deal to buy Novartis’s stake -Breaking

by Mike Robinson

[ad_1]

2/2
© Reuters. FILEPHOTO: Roche’s logo can be seen at Basel headquarters, Switzerland on January 30, 2020. REUTERS/Arnd Wiegmann/File Photo

2/2

ZURICH, Reuters – On Friday, Roche shareholders voted overwhelmingly in support of Novartis’s $20.7 billion purchase.

Roche called an extraordinary meeting of the general public to resolve issues related to the plan to unify the two pharmaceutical companies, which are both located in Basel and had been connected by this investment for over two decades.

Roche reported that shareholders approved the audited, statutory interim financial reports of the company up to 31 October 2021. The majority was 100.00%. The plan to cancel 53.3 million of the shares purchased was also supported by the shareholders with 99.85%.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]